NEWLY DIAGNOSED
Clinical trials for NEWLY DIAGNOSED explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients too frail for chemo?
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, azacytidine, and chidamide) for people newly diagnosed with a specific type of leukemia called acute monocytic leukemia who are not healthy enough for standard intensive chemotherapy. The goal is to see if this drug combo…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New hope for older AML patients: Four-Drug combo trial launches
Disease control Recruiting nowThis study compares four different drug combinations for adults newly diagnosed with acute myeloid leukemia (AML) who cannot tolerate or choose not to have intensive chemotherapy. The combinations include venetoclax and azacitidine (VA) alone or with either cladribine, chidamide,…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 00:31 UTC
-
New hope for blood cancer patients: experimental drug MP0533 enters human trials
Disease control Recruiting nowThis study tests a new drug called MP0533 in about 249 adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The main goals are to find a safe dose and see if the drug can shrink or control the cancer. Partici…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a milk thistle extract boost leukemia treatment?
Disease control Recruiting nowThis study tests whether adding silibinin (a liver-protecting supplement from milk thistle) to standard chemotherapy can improve outcomes for adults newly diagnosed with a common type of acute myeloid leukemia (non-M3). About 100 participants will receive either standard chemo al…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE4 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Blood cancer study seeks reasons behind transplant gap
Knowledge-focused Recruiting nowThis study watches over 1,300 people with blood cancers like acute leukemia to see how many get a stem cell transplant and why some don't. It aims to find barriers that stop patients from receiving this treatment, even when doctors recommend it. No new treatments are tested—just …
Matched conditions: NEWLY DIAGNOSED
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC